
Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …

Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

